Evidence Europe Congress 2017 London, England, UK 22-23 February 2017

Description:
Evidence Europe is your opportunity to engage and sit alongside the pioneers who are
driving forward effective health economics outcomes research and improving patient
outcomes through big data.

The event will cover a range of different topics including:
- How to embrace digital technologies in outcomes research
- Application of RWE in clinical development
- Partnerships in RWE
- Can we achieve better clinical development for rare diseases?
- How to integrate payer expectations in early drug development
- How to interpret and use RWD
- Maximise future opportunities in RWE
- Comparing different approaches to data analysis and HTA in mature versus emerging markets
- Sustaining value and quality in healthcare

Prices:
2 Day Package: GBP 1395
3 Day Package: GBP 1895

Speakers: Peter Speyer, Global Head of Real World Evidence Solutions, Novartis, Dr Sarah Wamala Andersson, Principal Research Scientist, Real World Evidence, Medical Affairs, Northern European Cluster, Eli Lilly and Company, Jitendar Sharma, Head Healthcare Technology, Ministry Health and Family Welfare India, Alicia Granados, Head Global HTA Scientific Strategy, Sanofi Genzyme, Mogens Westergaard, Medical Evidence Director, AstraZeneca